Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma

BACKGROUND: The treatment of oral squamous cell carcinoma (OSCC) following early detection is associated with good outcomes. Therefore, the survival and prognosis of OSCC patients could be hugely improved by identifying reliable biomarkers for the early diagnosis of the disease. Our previous methyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yi-Hui, He, Ru-Yin, Chou, Jian-Liang, Chan, Michael W-Y, Li, Yu-Fen, Tai, Chien-Kuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160550/
https://www.ncbi.nlm.nih.gov/pubmed/25179542
http://dx.doi.org/10.1186/s12967-014-0237-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160550/
https://www.ncbi.nlm.nih.gov/pubmed/25179542
http://dx.doi.org/10.1186/s12967-014-0237-7

Ejemplares similares